Skip to content

The use of anterior suspension combined with posterior reconstruction technique for improving the safety and efficacy of early urinary control recovery in high-risk prostate cancer patients after radical surgery: A prospective, randomized, parallel-controlled, single-blinded, single-center clinical trial

The use of anterior suspension combined with posterior reconstruction technique for improving the safety and efficacy of early urinary control recovery in high-risk prostate cancer patients after radical surgery: A prospective, randomized, parallel-controlled, single-blinded, single-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083098
Enrollment
Unknown
Registered
2024-04-16
Start date
2024-04-20
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Experimental group:The routine robotic intraperitoneal anterior approach surgery is performed by first exposing the anterior bladder and the retroperitoneal deep venous complex (DVC), followed by a pe
Control group:Routine robotic intraperitoneal anterior approach radical prostatectomy.

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: To standardize recruitment, participants must meet all of the following criteria: The pathological result of prostate biopsy is diagnosed as malignant prostate tumor. According to the D'Amico risk classification, they are considered high-risk, meeting one of the following conditions: a. PSA > 20ng/mol, b. GS > 7 (ISUP grades 4-5), c. Clinical staging of = cT2c. Life expectancy > 5 years. (According to WHO's life table by country, for Chinese males, i.e. under the age of 85) They agree to participate in the trial and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will be excluded from the study: History of prostate surgery, pelvic surgery, or urethral surgery. History of neoadjuvant radiotherapy. Concurrent neurogenic urinary dysfunction or urethral stricture. Clinical T4 or M1 staging.

Design outcomes

Primary

MeasureTime frame
Postoperative social urinary continence rate at 3 months;

Secondary

MeasureTime frame
Instant urinary continence condition;ICIQ-UI-SF score at 3 months postoperatively;Postoperative urinary continence condition at 1 month and 6 months;

Countries

China

Contacts

Public ContactMo Zhang

The First Affiliated Hospital of China Medical University

peterzhang623@gmail.com+86 135 5582 9122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026